S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
NASDAQ:CCXI

ChemoCentryx SEC Filings & 10K Form

$19.21
+1.01 (+5.55 %)
(As of 09/27/2021 04:00 PM ET)
Add
Compare
Today's Range
$18.35
$19.68
50-Day Range
$13.53
$19.21
52-Week Range
$9.53
$70.29
Volume3.67 million shs
Average Volume2.07 million shs
Market Capitalization$1.34 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.46

ChemoCentryx (NASDAQ:CCXI) SEC Filings

DateFilerForm TypeView
08/09/2021
3:34 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/06/2021
9:06 AM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2021
6:01 PM
Butt Tausif (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
6:52 AM
ChemoCentryx (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
05/24/2021
7:19 PM
ChemoCentryx (Issuer)
Tyree James L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2021
7:09 PM
ChemoCentryx (Issuer)
Parker Geoffrey M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2021
7:03 PM
ChemoCentryx (Issuer)
MCKINNELL HENRY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2021
6:55 PM
ChemoCentryx (Issuer)
Jain Rita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2021
6:47 PM
ChemoCentryx (Issuer)
FECZKO JOSEPH M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2021
6:39 PM
ChemoCentryx (Issuer)
Edwards Thomas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2021
11:54 AM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2021
6:48 PM
Butt Tausif (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
1:56 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2021
3:19 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/30/2021
7:45 PM
ChemoCentryx (Issuer)
Jain Rita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
7:28 PM
ChemoCentryx (Issuer)
Parker Geoffrey M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
10:04 AM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2021
7:39 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:33 PM
ChemoCentryx (Issuer)
Edwards Thomas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
3:15 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2021
8:17 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
8:12 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
8:05 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
8:00 PM
Butt Tausif (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
7:54 PM
ChemoCentryx (Issuer)
Kwan Pui San (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
3:31 PM
ChemoCentryx (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2021
11:13 AM
Butt Tausif (Reporting)
ChemoCentryx (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/16/2021
2:01 PM
ChemoCentryx (Subject)
Cormorant Asset Management, LP (Filed by)
Form SC 13G/A
02/11/2021
7:02 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2021
6:52 PM
ChemoCentryx (Issuer)
Edwards Thomas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
7:31 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
7:25 PM
ChemoCentryx (Issuer)
Kwan Pui San (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2021
7:05 PM
ChemoCentryx (Issuer)
Parker Geoffrey M. (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/04/2021
6:58 PM
ChemoCentryx (Issuer)
Edwards Thomas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
1:14 PM
ChemoCentryx (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/27/2021
7:22 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2021
6:25 PM
ChemoCentryx (Issuer)
Kwan Pui San (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
7:40 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
7:32 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
7:26 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2020
5:58 PM
ChemoCentryx (Issuer)
Edwards Thomas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2020
3:15 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2020
6:51 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
6:46 PM
ChemoCentryx (Issuer)
Kwan Pui San (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/10/2020
8:02 AM
ChemoCentryx (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/09/2020
3:16 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2020
3:15 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2020
3:33 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2020
3:15 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
3:15 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2020
6:10 PM
ChemoCentryx (Issuer)
Vifor Ltd (0001675217) (Reporting)
Vifor Fresenius Medical Care Renal Pharma Ltd. (Reporting)
Vifor Pharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2020
6:55 PM
ChemoCentryx (Issuer)
Vifor Ltd (0001675217) (Reporting)
Vifor Fresenius Medical Care Renal Pharma Ltd. (Reporting)
Vifor Pharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2020
6:53 PM
ChemoCentryx (Issuer)
Vifor Ltd (0001675217) (Reporting)
Vifor Fresenius Medical Care Renal Pharma Ltd. (Reporting)
Vifor Pharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2020
5:32 PM
ChemoCentryx (Issuer)
Vifor Ltd (0001675217) (Reporting)
Vifor Fresenius Medical Care Renal Pharma Ltd. (Reporting)
Vifor Pharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2020
7:00 PM
ChemoCentryx (Issuer)
Vifor Ltd (0001675217) (Reporting)
Vifor Fresenius Medical Care Renal Pharma Ltd. (Reporting)
Vifor Pharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2020
6:56 AM
ChemoCentryx (Subject)
Vifor Ltd (0001675217) (Filed by)
Form SC 13D/A
07/13/2020
6:18 PM
ChemoCentryx (Issuer)
Vifor Ltd (0001675217) (Reporting)
Vifor Fresenius Medical Care Renal Pharma Ltd. (Reporting)
Vifor Pharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2020
7:39 PM
ChemoCentryx (Issuer)
Vifor Ltd (0001675217) (Reporting)
Vifor Fresenius Medical Care Renal Pharma Ltd. (Reporting)
Vifor Pharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2020
5:57 PM
ChemoCentryx (Issuer)
Vifor Ltd (0001675217) (Reporting)
Vifor Fresenius Medical Care Renal Pharma Ltd. (Reporting)
Vifor Pharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
7:20 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
7:08 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
7:02 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
4:24 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2020
4:22 PM
ChemoCentryx (Filer)
Form 424B5
06/10/2020
4:01 PM
ChemoCentryx (Filer)
Form 424B5
06/05/2020
6:11 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
8:04 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
7:59 PM
ChemoCentryx (Issuer)
Tyree James L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
7:55 PM
ChemoCentryx (Issuer)
Parker Geoffrey M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
7:49 PM
ChemoCentryx (Issuer)
MCKINNELL HENRY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
7:45 PM
ChemoCentryx (Issuer)
Jain Rita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
7:39 PM
ChemoCentryx (Issuer)
FECZKO JOSEPH M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
7:34 PM
ChemoCentryx (Issuer)
Edwards Thomas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
7:31 AM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2020
3:45 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2020
6:50 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2020
6:45 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
3:44 PM
ChemoCentryx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2020
3:26 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2020
7:11 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2020
6:59 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2020
7:19 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2020
3:30 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2020
3:16 PM
ChemoCentryx (Filer)
Form DEF 14A
03/31/2020
7:07 PM
ChemoCentryx (Issuer)
Kwan Pui San (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2020
6:10 PM
ChemoCentryx (Issuer)
Jain Rita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2020
5:42 PM
ChemoCentryx (Issuer)
Parker Geoffrey M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2020
6:03 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2020
5:55 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2020
5:48 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2020
6:24 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2020
6:15 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2020
6:05 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
2:09 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
ChemoCentryx (Subject)
Form SC 13G/A
02/13/2020
7:00 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
6:50 PM
ChemoCentryx (Issuer)
Kwan Pui San (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
6:53 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2020
5:51 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
7:32 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
7:12 PM
ChemoCentryx (Issuer)
Parker Geoffrey M. (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
This page was last updated on 9/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.